A carregar...
Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial
Capecitabine and docetaxel have single-agent activity in upper gastrointestinal tumours, and have together demonstrated preclinical synergy and a survival benefit in breast cancer, and high response rates in first-line metastatic gastric cancer. This trial assessed the efficacy, safety and feasibili...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361804/ https://ncbi.nlm.nih.gov/pubmed/15942631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602645 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|